www.faf.cuni.cz|Students|Staff|E-mail

Home  >  Personal Profiles  >  Zitko Jan  >  List of Publications

List of Publications

Personal Profiles

List of Publications

  1. AL-OTAIBI, J. S.; SHEENA MARY, Y.; ZITKO, J.; VAN ALSENOY, C.; GAMBERINI, M. C. Concentration-dependent SERS, DFT, NCI, and molecular dynamics investigation of N-(5-chloropyrazin-2-yl)-4-ethylbenzamide (CEB) adsorbed on silver colloid. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026, vol. 360, 128065. [ISSN: 1386-1425], IF2024 = 4.6 (Q1), AIS2024 = 0.550 (Q2), doi: 10.1016/j.saa.2026.128065     Link to free access to full-text (until July 2026).

  2. JUHÁS, M.; BOUZ, G.; PANG, L.; WEEKS, S. D.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; HALÍŘOVÁ, M.; KUČEROVÁ-CHLUPÁČOVÁ, M.; DOLEŽAL, M.; ZITKO, J. Targeting Mycobacterium tuberculosis: The Role of Alkyl Substitution in Pyrazinamide Derivatives. ACS Omega, 2026, .vol. 11, no. 3, pp. 3937–3948. [ISSN: 2470-1343], IF2024 = 4.3 (Q2), AIS2024 = 0.673 (Q2), doi: 10.1021/acsomega.5c07249

  3. DIEPOLTOVÁ, A.; NAWROT, D. E.; JANĎOUREK, O.; JUHÁS, M.; BÁRTA, P.; VÁVROVÁ, P.; PALLABOTHULA, V. S. K.; DUDÁŠOVÁ-HATOKOVÁ, P.; VEJSOVÁ, M.; VOXOVÁ, B.; ÖSTERREICHER, J.; ŠTĚRBOVÁ-KOVAŘÍKOVÁ, P.; NACHTIGAL, P.; ZITKO, J.; KONEČNÁ, K. A new bactericidal chlorinated derivative containing 2-aminooxazole potentiates antibacterial action of colistin against multidrug-resistant acinetobacter baumannii.  Medical Microbiology and Immunology, 2025, vol. 214. no.1, article no. 44. [ISSN: 1432-1831], IF2024 = 3.0 (Q3Q3), AIS2024 = 0.845 (Q3Q2), doi: 10.1007/s00430-025-00854-y
  4. HOUNGBEDJI, P.-A.; NAWROT, D. E.; JANĎOUREK, O.; KONEČNÁ, K.; NOVÁK, M.; PATEROVÁ, P.; BÁRTA, P.; RAMBAHER, M. H.; NOVOTNÁ, E.; CASTELLANO, C.; MORI, M.; MENEGHETTI, F.; ZÁHORSZKÁ, M.; KORDULÁKOVÁ, J.; ZITKO, J. Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N’-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives. ChemMedChem, 2025, e202500085. [ISSN:1860-7179 Print, ISSN:1860-7187 Online], IF2024 = 3.4 (Q2Q2), AIS2024 = 0.626 (Q2Q2), doi: 10.1002/cmdc.202500085
  5. KERDA, M.; NAWROT, D.; SLECHTA, P.; DOMANSKÝ, M.; ASKARI, A.; KAMANGAR, H.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; HLBOČANOVÁ, I.; MACHÁČEK, M.; MORI, M.; MENEGHETTI, F.; DOLEŽAL, M.; ZITKO, J.; BOUZ, G. Novel quinazolinones active against multidrug-resistant Mycobacterium tuberculosis: synthesis, antimicrobial evaluation and in silico exploration of PonA1 as a potential target. ChemMedChem, 2025, e202500147. [ISSN:1860-7179 Print, ISSN:1860-7187 Online], IF2023 = 3.6 (Q2Q2), AIS2023 = 0.713 (Q2Q2), doi: 10.1002/cmdc.202500147
  6. NAWROT, D.; KOUTNÍKOVÁ, B.; JANĎOUREK, O.; KONEČNÁ, K.; NOVÁK, M.; PATEROVÁ, P.; BÁRTA, P.; BOUZ, G.; ZITKO, J.; DOLEŽAL, M. Antimicrobial and Antiproliferative Properties of 2-Phenyl-N-(Pyridin-2-yl)acetamides. Chem. Biol. Drug Des., 2025, vol. 105, no. 1, e70030. [eISSN 1521-4184], IF2023 = 3.2 (Q3), AIS2023 = 0.505 (Q3), doi: 10.1111/cbdd.70030
  7. SALAM, R.; BAKKER, M.; KRUTÁKOVÁ, M.; ŠTEFELA, A.; PÁVEK, P.; DUINTJER TEBBENS, J.; ZITKO, J. The discovery of a new nonbile acid modulator of Takeda G protein-coupled receptor 5: An integrated computational approach. Arch. Pharm., 2025, vol. 358, no. 1, e2400423. [eISSN 1521-4184], IF2023 = 4.3 (Q1Q2), AIS2023 = 0.559 (Q2Q3), doi: 10.1002/ardp.202400423,
  8. PALLABOTHULA, V. S. K.; ABDALRAHMAN, N. T.; MORI, M.; FEKRI, A. H.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NOVÁK, M.; DUDÁŠOVÁ-HATOKOVÁ, P.; ŠTĚRBOVÁ-KOVAŘÍKOVÁ, P.; CASTELLANO, C.; MENEGHETTI, F.; VILLA, S.; KUNEŠ, J.; JUHÁS, M.; ZITKO, J. A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity. Arch. Pharm., 2024, vol. 357, e2400171 [ISSN 0365-6233], IF2023 = 4.3 (Q2), doi: doi.org/10.1002/ardp.202400171
  9. KERDA, M.; ŠLECHTA, P.; JAND'OUREK, O.; KONEČNÁ, K.; HATOKOVÁ, P.; PATEROVÁ, P.; ZITKO, J. N-Pyrazinylhydroxybenzamides as biologically active compounds: a hit-expansion study and antimicrobial evaluation. Future Med. Chem., 2023,  vol. 15, no. 19, p. 1791-1806. [ISSN 1756-8927], IF2022 = 4.2 (Q2), doi: 10.4155/fmc-2023-0189
  10. NAWROT, D. E.; BOUZ, G.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; NOVÁK, M.; KUČERA, R.; ZEMANOVÁ, J.; FORBAK, M.; KORDULÁKOVÁ, J.; PAVLIŠ, O.; KUBÍČKOVÁ, P.; DOLEŽAL, M.; ZITKO, J. Antimycobacterial pyridine carboxamides: From design to in vivo activity. Eur. J. Med. Chem., 2023, vol. 258, 115617.  [ISSN 0223-5234], IF2022 = 6.700 (Q1), doi: 10.1016/j.ejmech.2023.115617
  11. BOUZ, G.; ŠLECHTA, P.; JAND’OUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; NOVÁK, M.; KUČERA, R.; DAL, N.-J. K.; FENAROLI, F.; ZEMANOVÁ, J.; FORBAK, M.; KORDULÁKOVÁ, J.; PAVLIŠ, O.; KUBÍČKOVÁ, P.; DOLEŽAL, M.; ZITKO, J. Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid. ACS Infect. Dis., 2023, vol. 9, no. 1, p. 79-96. [ISSN 2373-8227], IF2021 =5.578 (D1), doi: 10.1021/acsinfecdis.2c00433  Free Access Link (Valid for 50 downloads, for 1 year)
  12. PALLABOTHULA, V.S.K.; KERDA, M.; JUHÁS, M.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; PATEROVÁ, P.; ZITKO, J. Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity. Biomolecules ,2022, vol. 12, article no. 1561. [ISSN 2218-273X], IF2021 = 6.064, doi: 10.3390/biom12111561
  13. JUHÁS, M.; BACHTÍKOVÁ, A.; NAWROT, D.E.; HATOKOVÁ, P.; PALLABOTHULA, V.S.K.; DIEPOLTOVÁ, A.; JANĎOUREK, O.; BÁRTA, P.; KONEČNÁ, K.; PATEROVÁ, P.; ŠESTÁK, V.; ZITKO, J. Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals, 2022, vol. 15, article no. 580. [ISSN 1424-8247], IF2020 = 5.863 (Q1Q1), doi:  10.3390/ph15050580
  14. JUHÁS, M.; PALLABOTHULA, V. S. K.; GRABRIJAN, K.; ŠIMOVIČOVÁ, M.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; PATEROVÁ, P.; GOBEC, S.; SOSIČ, I.; ZITKO, J. Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1. Bioorg. Chem., 2022, vol. 118, article no. 105489.  [ISSN 0045-2068], IF2020 = 5.275, doi: 10.1016/j.bioorg.2021.105489     Free Access link until Jan 20, 2022 
  15. BOUZ, G.; BOUZ, S.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; VINŠOVÁ, J.; DOLEŽAL, M.; ZITKO, J. Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides. Pharmaceuticals, 2021, vol. 14, article no. 768. [ISSN 1424-8247], IF2020 = 5.863 (Q1Q1), doi: 10.3390/ph14080768
  16. PANG, L.; WEEKS, S.D.; JUHÁS, M.; STRELKOV, S.V.; ZITKO, J.; VAN AERSCHOT, A. Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies. Int. J. Mol. Sci., 2021, vol. 22, article no. 7793. [ISSN 1422-0067], IF2020 = 5.923 (Q1Q2), doi: 10.3390/ijms22157793
  17. BOUZ, G.; ZITKO J. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. Bioorg. Chem., 2021, vol. 110, article no. 104806. [ISSN 0045-2068], IF2020 = 5.275, doi: 10.1016/j.bioorg.2021.104806
  18. NAWROT, D.; SUCHÁNKOVÁ, E.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; DOLEŽAL, M.; ZITKO, J. N‐pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds. Chem. Biol. Drug. Des., 2021, vol. 97, p. 686–700. [ISSN 1747-0277], IF2020 = 2.817, doi: 10.1111/cbdd.13804
  19. JUHÁS, M.; ZITKO, J. Molecular Interactions of Pyrazine-based Compounds to Proteins. J. Med. Chem. 2020, vol. 63, no. 17, p. 8901–8916. [ISSN 0022-2623], IF2020 = 7.446 (D1), doi: 10.1021/acs.jmedchem.9b02021
  20. AMBROŻKIEWICZ, W.; KUČEROVÁ-CHLUPÁČOVÁ, M.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; VINŠOVÁ, J.; DOLEŽAL, M.; ZITKO, J. 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation. Molecules, 2020, vol. 25, article no. 1561. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25071561
  21. JUHÁS, M.; KUČEROVÁ, L.; HORÁČEK, O.; JANĎOUREK, O.; KUBÍČEK, V.; KONEČNÁ, K.; KUČERA, R.; BÁRTA, P.; JANOUŠEK, J.; PATEROVÁ, P.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—The Synthesis and Biological Evaluation of Enantiomers. Molecules, 2020, vol. 25, article no. 1518. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25071518
  22. BOUZ, G.; JUHÁS, M.; PAUSAS OTERO, L.; PAREDES DE LA RED, C.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; KUBÍČEK, V.; JANOUŠEK, J.; DOLEŽAL, M.; ZITKO, J. Substituted N-(pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-infective Evaluation, Cytotoxicity, and In silico Studies. Molecules, 2020, vol. 25, no. 1, article no. 138. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25010138
  23. BEEGUM, S.; MARY, Y. S.; MARY, Y. S.; THOMAS, R.; ARMAKOVIĆ, S.; ARMAKOVIĆ, S. J.; ZITKO, J.; DOLEŽAL, M.; VAN ALSENOY, C. Exploring the detailed spectroscopic characteristics, chemical and biological activity of two cyanopyrazine-2-derivatives using experimental and theoretical tools. Spectrochim. Acta Part A: Mol. Biomol. Spectr., 2020, vol. 224, art. no. 117414. [ISSN 1386-1425], IF2020 = 4.098, doi: 10.1016/j.saa.2019.117414
  24. BOUZ, G.; SEMELKOVÁ, L.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity. Molecules, 2019, vol. 24, no. 7, article no. 1212. [ISSN 1420-3049], IF2019 = 3.267, doi: 10.3390/molecules24071212
  25. ZITKO, J.; MINDLOVÁ, A.; VALÁŠEK, O.; JANĎOUREK, O.; PATEROVÁ, P.; JANOUŠEK, J.; KONEČNÁ, K.; DOLEŽAL, M. Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents. Molecules, 2018, vol. 23, no. 9, article no. 2390. [ISSN 1420-3049], IF2017 = 3.098, doi: 10.3390/molecules23092390
  26. ZITKO, J.; JANĎOUREK, O.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUNEŠ, J.; VINŠOVÁ, J.; DOLEŽAL, M. Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with 4-phenylthiazol-2-amine scaffold. MedChemComm, 2018, vol. 9, p. 685–696. [ISSN 2040-2503], IF2016: 2.608, doi: 10.1039/C8MD00056E
  27. ZITKO, J.; DOLEŽAL, M. Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis. Curr. Med. Chem., 2018. vol. 25, No. 38, p. 5142–5167. [ISSN 1875-533X], IF2017: 3.469, doi: 10.2174/0929867324666170920154325
  28. MUCAJI, P.; ATANASOV, A. G.; BAK, A.; KOZIK, V.; SIERON, K.; OLSEN, M.; PAN, W.; LIU, Y.; HU, S.; LAN, J.; HAIDER, N.; MUSIOL, R.; VANCO, J.; DIEDERICH, M.; JI, S.; ZITKO, J. The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †. Molecules, 2017, vol. 22, no. 11, article no. 1848. [ISSN 1420-3049], IF2016 = 2.861, doi:10.3390/molecules22111848
  29. BOUZ, G.; JUHÁS, M.; NIKLOVÁ, P.; JANĎOUREK, O.; PATEROVÁ, P.; JANOUŠEK, J.; TŮMOVÁ, L.; KOVALÍKOVÁ, Z.; KASTNER, P.; DOLEŽAL, M.; ZITKO, J. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. Molecules, 2017, vol. 22, no. 10, article no. 1797. [ISSN 1420-3049], IF2016 = 2.861, doi: 10.3390/molecules22101797
  30. SEMELKOVÁ, L.; JANOŠCOVÁ, P.; FERNANDES, C.; BOUZ, G.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids. Molecules 2017, vol. 22, no. 9, Article No. 1491.  [ISSN 1420-3049] IF2016 = 2.861, doi: 10.3390/molecules22091491
  31. SEMELKOVÁ, L.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; TREJTNAR, F.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation. Molecules, 2017, vol. 22, no. 3, Article No. 495. [ISSN 1420-3049] IF2015 = 2.465, doi:10.3390/molecules22030495
  32. JANDOUREK, O.; TAUCHMAN, M.; PATEROVA, P.; KONECNA, K.; NAVRATILOVA, L.; KUBICEK, V.; HOLAS, O.; ZITKO, J.; DOLEZAL, M. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation. Molecules, 2017, vol. 22, no. 2, Article No. 223. [ISSN 1420-3049] IF2015 = 2.465, doi: 10.3390/molecules22020223
  33. P.K. RANJITH, ; EBTEHAL S. AL-ABDULLAH, FATMAH A.M. AL-OMARY, ALI A. EL-EMAM, P.L. ANTO, MARY Y. SHEENA, STEVAN ARMAKOVIĆ, SANJA J. ARMAKOVIĆ, JAN ZITKO, MARTIN DOLEZAL, C. VAN ALSENOY. FT-IR and FT-Raman characterization and investigation of reactive properties of N-(3-iodo-4-methylphenyl)pyrazine-2-carboxamide by molecular dynamics simulations and DFT calculations. J. Mol. Struct., 2017, vol. 1136, p. 14–24. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2017.01.079
  34. BEEGUM, S.; MARY, Y. S.; VARGHESE, H. T.; PANICKER, C. Y.; ARMAKOVIĆ, S.; ARMAKOVIĆ, S. J.; ZITKO, J.; DOLEŽAL, M.; VAN ALSENOY, C. Vibrational spectroscopic analysis of cyanopyrazine-2-carboxamide derivatives and investigation of their reactive properties by DFT calculations and molecular dynamics simulations. J. Mol. Struct., 2017, vol. 1131, p. 1–15. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2016.11.044
  35. ZITKO, J.; DOLEŽAL, M. Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 – 2015). Exp. Opin. Ther. Pat., 2016, vol. 26, p. 1079-1094.  [ISSN 1354-3776 (Print)], [ISSN 1744-7674 (Online)]. IF2015: 4.626. doi: 10.1080/13543776.2016.1211112.
  36. SEBASTIAN, S. H. R.; AL-ALSHAIKH, M. A.; EL-EMAM, A. A.; PANICKER, C. Y.; ZITKO, J.; DOLEZAL, M.; VAN ALSENOY, C. Spectroscopic, quantum chemical studies, Fukui functions, in vitro antiviral activity and molecular docking of 5-chloro-N-(3-nitrophenyl)pyrazine-2-carboxamide. J. Mol. Struct.,  2016, vol. 1119, p. 188–199. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2016.04.088
  37. ZITKO, J.; SERVUSOVA-VANASKOVA, B.; PATEROVA, P.; NAVRATILOVA, L.; TREJTNAR, F.; KUNES, J.; DOLEZAL, M. Design, Synthesis and Antimycobacterial Evaluation of Some New N-Phenylpyrazine-2-Carboxamides. Chem. Pap., 2016, vol. 70, no. 5, p. 649–657. [ISSN (Online) 1336-9075], [ISSN (Print) 0366-6352], IF2014 = 1.468. doi: 10.1515/chempap-2015-0246
  38. ZITKO, J.; DOLEŽAL, M. Indole-carboxamide derivatives: a patent evaluation of WO2015036412A1. Exp. Opin. Ther. Pat., 2015, vol. 25, p. 1487–1494. [ISSN 1354-3776]. IF2014 = 4.297. doi: 10.1517/13543776.2015.1101066
  39. RESMI, K. S.; PANICKER, C. Y.; ZITKO, J.; DOLEZAL, M.; WAR, J.A.; SRIVASTAVA, S. K.; VAN ALSENOY, C. FT-IR, FT-Raman, NBO, HOMO-LUMO analysis and molecular docking study of 5-chloro-N-(2-fluorophenyl)pyrazine-2-carboxamide. Sci. Lett., 2015, vol. 4, p. 216. [ISSN 2454–7239].
  40. SERVUSOVA-VANASKOVA, B.; JANDOUREK, O.; PATEROVA, P.; KORDULAKOVA, J.; PLEVAKOVA, M.; KUBICEK, V.; KUCERA, R.; GARAJ, V.; NAESENS, L.; KUNES, J.; DOLEZAL, M.; ZITKO, J. Alkylamino derivatives of N-benzylpyrazine-2-carboxamide: Synthesis and antimycobacterial evaluation. MedChemComm, 2015, vol. 6, p. 1311–1317. [ISSN 2040-2503], IF2013 = 2.626. doi: 10.1039/C5MD00178A
  41. SEMELKOVA, L.; KONECNA, K.; PATEROVA, P.; KUBICEK, V.; KUNES, J.; NOVAKOVA, L.; MAREK, J.; NAESENS, L.; PESKO, M.; KRALOVA, K.; DOLEZAL, M.; ZITKO, J. Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides. Molecules, 2015, vol. 20, p. 8687–8711. [ISSN 1420-3049], IF2013 = 2.095. doi: 10.3390/molecules20058687
  42. ZITKO, J.; FRANCO, F.; PATEROVÁ, P. Synthesis and anti-infective evaluation of 5-amino-N-phenylpyrazine-2-carboxamides. Čes. Slov. Farm., 2015, vol. 64, p. 19–24. [ISSN 1210-7816].
  43. SERVUSOVÁ-VAŇÁSKOVÁ, B.; PATEROVÁ P.; GARAJ, V.; MANDÍKOVA, J.; KUNEŠ J.; NAESENS, L.; JÍLEK, P.; DOLEŽAL, M.; ZITKO, J. Synthesis and antimicrobial evaluation of 6-alkylamino-N-phenyl-pyrazine-2-carboxamides. Chem. Biol. Drug Des., 2015, vol. 86, p. 674–681. [ISSN 1747-0285].  IF2013 = 2.507. doi: 10.1111/cbdd.12536
  44. ZITKO, J.; SERVUSOVÁ, B.; JANOUTOVÁ, A.; PATEROVÁ, P.; MANDÍKOVÁ, J.; GARAJ, V.; VEJSOVÁ, M.; MAREK, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides. Bioorg. Med. Chem., 2015, vol. 23, p. 174–183. [ISSN 0968-0896], IF2013 = 2.951. doi: 10.1016/j.bmc.2014.11.014
  45. DOLEŽAL, M.; ZITKO, J. Pyrazine Derivatives: a patent review (June 2012-present). Exp. Opin. Ther. Pat., 2015, vol. 25, p. 33–47. [ISSN 1354-3776]. IF2013 = 3.441. doi: 10.1517/13543776.2014.982533
  46. JANĎOUREK, O.; DOLEŽAL, M.; KUNEŠ, J.; KUBÍČEK, V.; PATEROVÁ, P.; PEŠKO, M.; BUCHTA, V.; KRÁĽOVÁ, K.; ZITKO, J. New potentially active pyrazinamide derivatives synthesized under microwave conditions. Molecules, 2014, vol. 19, p. 9318–9338.  [ISSN 1420-3049], IF2013 = 2.095. doi: 10.3390/molecules19079318
  47. SERVUSOVÁ, B.; MANDÍKOVÁ, J.; PATEROVÁ, P.; KUBÍČEK, V.; KUČERA, R.; DOLEŽAL, M.; ZITKO, J. Alkylamino derivatives of pyrazinamide: Synthesis and antimycobacterial evaluation. Bioorg. Med. Chem. Lett., 2014, vol. 24, no. 2, p. 450–453. [ISSN 0960-894X] IF2012 = 2.338, doi: 10.1016/j.bmcl.2013.12.054
  48. ZITKO, J.; SERVUSOVÁ, B.; PATEROVÁ, P.; MANDÍKOVÁ, J.; KUBÍČEK, V.; KUČERA, R.; HRABCOVÁ, V.; KUNEŠ, J.; SOUKUP, O.; DOLEŽAL, M. Synthesis, Antimycobacterial Activity and in Vitro Cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides. Molecules, 2013, vol. 18, no. 12, p. 14807–14825. [ISSN 1420-3049], IF2012 = 2.428, doi: 10.3390/molecules181214807
  49. ZITKO, J.; PATEROVÁ, P.; KUBÍČEK, V.; MANDÍKOVÁ, J.; TREJTNAR, F.; KUNEŠ, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution. Bioorg. Med. Chem. Lett., 2013, vol. 23, no. 2, p. 476–479. [ISSN 0960-894X], http://dx.doi.org/10.1016/j.bmcl.2012.11.052, IF2011 = 2.554
  50. SERVUSOVÁ, B.; VOBICKOVÁ, J.; PATEROVÁ, P.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides. Bioorg. Med. Chem. Lett., 2013, vol. 23, 3589–3591. [ISSN 0960-894X], DOI: 10.1016/j.bmcl.2013.04.021. IF = 2.554
  51. DOLEŽAL, M.; ZITKO, J.; JAMPÍLEK, J. Pyrazinecarboxylic acid derivatives with antimycobacterial activity. Chapter 10, p. 233–262. In “Understanding Tuberculosis - New approaches for fighting against drug-resistance“ by Pere-Joan Cardona (ed.), 1st ed., Vienna, InTech, February 2012, 376 p. [ISBN 978-953-307-948-6]
  52. ZITKO, J.; JAMPÍLEK, J.; DOBROVOLNÝ, L.; SVOBODOVÁ, M.; KUNEŠ, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles. Bioorg. Med. Chem. Lett., 2012, vol. 22, no. 4, p. 1598–1601. DOI: 10.1016/j.bmcl.2011.12.129, [ISSN 0960-894X], IF2011 = 2.554
  53. ZITKO, J.; DOLEŽAL, M.; Svobodová, M.; VEJSOVÁ, M.; Kuneš, J.; KUČERA, R.; JÍLEK, P. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides. Bioorg. Med. Chem., 2011, vol. 19, no. 4, p. 1471–1476. [ISSN 0968-0896], IF2011 = 2.921
  54. DOLEŽAL, M.; KEŠETOVIČ, D.; ZITKO, J. Antimycobacterial evaluation of pyrazinecarboxylic acid derivatives. Curr. Pharm. Design, 2011, vol. 17, no. 32, p. 3506–3514. [ISSN 1381-6128], IF2011 = 3.870
  55. DOLEZAL, M.; ZITKO, J.; OSICKA, Z.; KUNES, J.; VEJSOVA, M.; BUCHTA, V.; DOHNAL, J.; JAMPILEK, J.; KRALOVA, K. Synthesis, Antimycobacterial, Antifungal and Photosynthesis-Inhibiting Activity of Chlorinated N-phenylpyrazine-2-carboxamides. Molecules 2010, vol. 15, p. 8567-8581. [ISSN 1420-3049], IF2010 = 1.988. doi: 10.3390/molecules15128567
  56. DOLEZAL, M.; ZITKO, J.; KESETOVICOVA, D.; KUNES, J.; SVOBODOVA, M. Substituted N‑Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation. Molecules 2009, vol. 14, p. 4180-4189. [ISSN 1420-3049], IF2009 = 1.738. doi: 10.3390/molecules14104180
© 2026 Charles University, Faculty of Pharmacy in Hradec Králové | Website information | Kentico CMS